| Financial Year |
March 31 2023 |
| Monetary Funds |
711,355,626.04 |
| Held-for-trading Financial Assets |
103,937,127.96 |
| Notes Receivable |
127,529,224.39 |
| Accounts Receivable |
1,998,056,026.67 |
| Advances to Suppliers |
53,841,886.96 |
| Other Receivables |
32,818,207.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,719,539,042.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
316,600,817.46 |
| Total Current Assets |
5,302,968,815.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
37,938,396.36 |
| Fixed Assetes |
746,536,498.25 |
| Under-construction Projects |
135,508,876.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
248,788,215.18 |
| R&D expenses |
-- |
| Goodwill |
15,333,021.13 |
| Long-Term Deferred and Prepaid Expenses |
3,690,141.66 |
| Deferred Income Tax Assets |
96,987,736.86 |
| Other Non-Current Assets |
38,384,368.01 |
| Sub-Total of Non-Current Assets |
1,511,461,485.88 |
| Total Assets |
6,814,430,301.09 |
| Short-Term Loans |
223,051,962.63 |
| Trading Financial liabilities |
17,392,790.64 |
| Notes Payable |
1,151,898,182.82 |
| Accounts Payable |
431,229,523.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,664,614.80 |
| Taxes Payable |
32,721,582.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,063,604.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,089,519.86 |
| Other Current Liabilities |
55,181,594.10 |
| Sub-Total of Current Liabilities |
2,368,187,971.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
63,007,451.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,961,525.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
297,636,255.37 |
| Total Liabilities |
2,665,824,226.97 |
| Paid-In Capital(Or Share Stock) |
934,899,232.00 |
| Capital Surplus |
1,562,072,506.40 |
| Surplus Reserve |
120,133,729.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,548,735,613.58 |
| Minority Stockholder's Interest |
18,926,816.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,129,679,258.03 |
| Owner's Equity（Stockholder's Equity） |
4,148,606,074.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,814,430,301.09 |
